Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | DDX3X | O00571 | 2/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29478358 | 1.00 | ALDH1A1 (0.60) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL18391079 | 0.95 | ALDH1A1 (0.54) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL29008615 | 0.94 | ALDH1A1 (0.54) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL3786374 | 0.91 | CYP17A1 (0.57) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL15648062 | 0.89 | NAMPT (0.62) | ALDH1A1DDX3XHDAC3HDAC8HDAC6 | |
| SCHEMBL29029431 | 0.88 | HDAC3 (0.56) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL13622713 | 0.87 | AURKA (0.48) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL13622966 | 0.87 | PTGS1 (0.55) | ALDH1A1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL13622710 | 0.87 | ALDH1A1 (0.47) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 | |
| SCHEMBL3780607 | 0.86 | CYP17A1 (0.49) | ALDH1A1DDX3XHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286583-B | Diphenylamino pyrimidine-containing compound, preparation and application thereof as HDACs enzyme inhibitor | 山东大学 | 2024-01-30 | — | — | CN | claimed |
| CN-113461636-B | Benzothiazole-containing phenylalanine derivative and preparation method and application thereof | 山东大学 | 2023-08-08 | — | — | CN | claimed |
| CN-115286583-A | Diphenylaminopyrimidine-containing compound, preparation and application thereof as HDACs enzyme inhibitor | 山东大学 | 2022-11-04 | — | — | CN | claimed |
| CN-113461636-A | Benzothiazole-containing phenylalanine derivative and preparation method and application thereof | 山东大学 | 2021-10-01 | — | — | CN | claimed |
| CN-107930412-B | Preparation method of acid-resistant poly (amide-triazine-amine) nanofiltration composite membrane | 浙江大学 | 2020-01-14 | — | — | CN | claimed |
| CN-107930412-A | A kind of anti-acid gathers（Acid amides atrazin）The preparation method of Nano filtering composite membrane | 浙江大学 | 2018-04-20 | — | — | CN | claimed |
| CN-106243044-A | Pyridine derivatives containing halo acrylamide side chain and preparation and application | 浙江大学 | 2016-12-21 | — | — | CN | claimed |
| US-12637467-B2 | Inhibitor of BTK and mutants thereof | NEWAVE PHARMACEUTICAL INC. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-122059950-A | Compounds with proteasome agonistic activity, preparation method and application thereof | 浙大城市学院 | 2026-05-19 | — | — | CN | disclosed |
| US-12583862-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | NURIX THERAPEUTICS, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| CN-121673187-A | Diamine monomer containing amide structure, polyamide-imide, and preparation method and application thereof | 天津科技大学 | 2026-03-17 | — | — | CN | disclosed |
| US-20260071223-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE | ARROWHEAD PHARMACEUTICALS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260035378-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | NURIX THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-0672037-B1 | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK-MODULATORS | GLAXO GROUP LTD (GB) | 1998-07-08 | — | — | EP | disclosed |
| US-5770736-A | DIAZONIUM-, AZIDO-, OR AZOCARBOXYLATE-DERIVATIZED POLYPHENYLENE AMIDATE COMPOUNDS | NORTHEASTERN UNIVERSITY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5760032-A | GASTROINTESTINAL DISORDERS AND NERVOUS SYSTEM DISORDERS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| EP-0776892-A1 | THIENYLAZOLE COMPOUND AND THIENOTRIAZOLODIAZEPINE COMPOUND | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
| EP-0672037-A1 | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK-MODULATORS | GLAXO GROUP LIMITED (GB) | 1995-09-20 | — | — | EP | disclosed |
| CN-1093085-A | Sulfonamide derivatives | GLAXO GROUP LTD (GB) | 1994-10-05 | — | — | CN | disclosed |
| WO-1994013648-A1 | 1,4-BENZODIAZEPINE DERIVATIVES AND THEIR USE AS CCK-MODULATORS | GLAXO GROUP LIMITED (GB) | 1994-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071223-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO ADIPOSE TISSUE | FABP4, PLIN1, PLIN3 | ALDH1A1 1769/4885DDX3X 1229/4885HDAC3 773/4885 |
| US-12637467-B2 | Inhibitor of BTK and mutants thereof | BTK, CNKSR1, SYK | ALDH1A1 4481/4885DDX3X 3260/4885HDAC3 1118/4885 |
| US-20260035378-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | BTK, PSMB2, PSMB1 | ALDH1A1 4621/4885DDX3X 1995/4885HDAC3 843/4885 |
| US-12583862-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | BTK, PSMB2, PSME3 | ALDH1A1 4714/4885DDX3X 1320/4885HDAC3 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.